🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The state of cell and gene therapies? Hear me "cell it like it is" on Transformation in Trials podcast h/t Sam Parnell, Ivanna Rosendal ISCT #celltherapy #genetherapy #Immunotherapy youtube.com/@transformatio…

Since 2001, ACGT has awarded 69 grants and invested more than $37 million in cell and gene therapy research. The foundation’s grants have helped launch scientists’ careers, support groundbreaking clinical trials, and lead to FDA approvals.

Today = 7th anniversary of the 1st FDA approved gene therapy. I was in Boston to give a talk. Email from Novartis came in "Congratulations" Here's my phone an hour after notice came. To all patients who enrolled in clinical trials, have received CAR T cells, to families, &

Elated that 10 years into the founding of the Delgoffe Lab, I've been officially promoted to Professor of Immunology at University of Pittsburgh Pitt Health Sciences UPMC Hillman Cancer Center! It has been a fun and exciting journey, that could not occurred without my incredible colleagues and trainees. Onward!

If you are attending Society for Immunotherapy of Cancer annual meeting, Alliance for Cancer Gene Therapy symposium with DR. Crystal Mackall and Dr. Shari Pilon-Thomas is on Friday November 8, 11:30-1:30 Registration is open but space is limited - link below: acgt.givevirtuous.org/Event/acgt-sit…

El Rey recibe al ganador de la IV edición del “Abarca Prize”, el Dr. Carl H. June, profesor de la cátedra Richard W. Vague de Inmunoterapia en Penn Medicine y director del Instituto Parker de Inmunoterapia del Cáncer. ➡️casareal.es/ES/Actividades…

Alliance for Cancer Gene Therapy is holding a lunch symposium during the Society for Immunotherapy of Cancer Annual Meeting on Friday 8th featuring speakers Drs. Crystal Mackall, Shari Pilon-Thomas and George Coukos. Registration is almost full but here's the link! acgt.givevirtuous.org/Event/acgt-sit… #SITC2024

If you are attending @SITCcancer #SITC2024 but missed today's TIL Symposium, join ACGT on Friday and hear from Shari Pilon Thomas Moffitt Cancer Center and George Coukos on the future of TIL therapy! Registration link is below - a few seats left so don't wait! acgt.givevirtuous.org/Event/acgt-sit…

New CAR T-Cell Therapy Approved for Leukemia - The FDA has approved AUCATZYL® (obecabtagene autoleucel – obe-cel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). autolus.gcs-web.com/news-releases/…

Sign up today to receive ACGT’s monthly e-newsletter, highlighting the latest developments in cell and gene therapy for cancer: acgtfoundation.org/who-we-are/con…

Last month, ACGT held its annual scientific summit – ACGT Summit 2025 – an invitation-only gathering bringing together top scientists in cancer cell and gene therapy. Read more about Summit 2025: acgtfoundation.org/news/acgt-summ…

If you, or someone you know, has received cell and gene therapy for cancer and is in remission please share your experience with us. Survivor stories can inspire & empower others to learn more about cell and gene therapy. Please email David Statman at [email protected]

ACGT is now accepting applications for the 2025 Investigator Awards in Cell and Gene Therapy for Gynecological Research, as well as in Breast Cancer. The Letter of Intent deadline is May 16. Visit our website for more details: tinyurl.com/2d75sa2v

ALERT: ACGT has two open Requests for Applications for cancer cell and gene therapy research with LOIs due next week! Our focus this year is on women's cancers - learn more on our website: acgtfoundation.org/groundbreaking…

Recently, our director Dr. Sanaz Memarzadeh was a panelist at the Alliance for Cancer Gene Therapy Alliance for Cancer Gene Therapy Summit. She discussed the challenges our lab & others face in developing gene therapies for Women’s Cancer as well as the instrumental progress that has been made.

Scientists, There’s only one day left to submit a pre-application Letter of Intent for our 2025 Investigator Awards in Cell and Gene Therapy for Gynecological Research and Breast Cancer. Visit the ACGT website for full details:  acgtfoundation.org/groundbreaking…

NG34C, A Novel Oncolytic Virus Expressing Truncated GADD34 Gene for Glioblastoma “What makes funding from ACGT impactful is it fills a critical gap between the initial scientific discovery and running the exciting clinical trials. This in-between phase is crucial to advancing

Congratulations to ACGT Board member Bruce Levine, and ACGT SAC members, Carl June, Michel Sadelain, and Isabelle Riviere for receiving the 2025 Richard N. Merkin Prize in Biomedical Technology for their roles in developing CAR T cell therapy! Read more: tinyurl.com/y65cuk9e

Cell and gene therapies are helping cancer patients become cancer survivors. Read about some of these survivor stories on ACGT’s website: acgtfoundation.org/for-patients/p… #NationalCancerSurvivorsMonth

The ACGT – Edward Netter Memorial Investigator Award in Cell and Gene Therapy Research for Pancreatic Cancer has been awarded to a collaboration between Ben Z. Stanger, MD, PhD and Carl June, MD. Read more: acgtfoundation.org/news/alliance-…